Source disclosure: March 05, 2026, 12:00 JST
Published by Pulse News Wire: March 05, 2026, 12:09 JST
ONO PHARMACEUTICAL CO.,LTD. [4528.T]
TOKYO, Mar 05 (Pulse News Wire) – ONO Pharmaceutical CO.,LTD. (4528.T) resolved at its board meeting held on March 05 to issue 8,398,300 ordinary shares to an Employee Stock Ownership Plan (ESOP) trust.
The share issuance will take place on March 25, 2026, at a price of ¥2,435.5 per share, totaling ¥20,454,059,650. The shares are intended for distribution to eligible employees of Deciphera Pharmaceuticals, Inc., a U.S. subsidiary of Ono Pharmaceutical. The ESOP trust was established to provide long-term incentives to the company's U.S.-based workforce.
The share dilution rate is estimated at 1.68%, based on the total number of outstanding shares as of September 30, 2025. Ono Pharmaceutical’s board determined that the share issuance would not significantly impact the stock market due to the gradual nature of the distribution process. The company also noted that the share price used for the valuation was the closing price on the Tokyo Stock Exchange on March 04, 2026, ensuring objectivity and reasonableness in the calculation method. All four directors, including two external members, confirmed the fairness of the pricing mechanism.
AI-translated content. 🟢 Confidence: High See terms • Original filing